# Current state
The market resolves YES if the US and China reach a publicly announced, mutual tariff/trade agreement (or officially confirmed mutual tariff reduction) by Dec 31, 2026. As of the current data, a one-year Busan truce (Oct 30, 2025) and a follow-on May 2026 Trump state visit to Beijing have produced tariff reductions and commitments, but reporting characterizes these as a "tactical truce"/vague "deals," not unambiguously a single comprehensive formal agreement — creating resolution ambiguity the market is already pricing at ~85% YES.
# Timeline of key events
- 2018-2019: US-China trade war escalates; Dec 2018 G20 truce (confirmed, per Wikipedia/base-rate research).
- 2020-01: "Phase One" trade agreement signed (confirmed, Wikipedia).
- 2025 (through 2025): 145%/125% tit-for-tat tariffs; multiple partial truces — Geneva (May 2025) and August 2025 extension (confirmed, code_execution/base-rate research).
- 2025-10-30: Trump-Xi Busan/APEC summit — one-year trade truce announced: US cuts fentanyl tariff 20%→10%, suspends threatened 100% hike, extends 24% reciprocal-rate reduction through Nov 10, 2026 (confirmed, wiley.law).
- 2025-11 (early Nov): White House fact sheet formalizes deal elements — China extends tariff-exclusion process for US imports through Dec 31, 2026, soybean purchase commitments, semiconductor probe terminations (confirmed, whitehouse.gov).
- 2026-05-13/15: Trump state visit to Beijing (2nd term, 2nd China visit) (confirmed, Wikipedia).
- 2026-05-18: CNN reports outcomes as vague ("more vibes than details"); Beijing readout doesn't fully confirm US claims (reported).
- 2026-05-20: Bessent says US "not in a rush" to extend/renew truce expiring Nov 10, 2026; possible Trump-Xi meetings at Nov APEC (China) and Dec G20 (Florida) (reported, Al Arabiya).
- 2026-07 to 2026-08: Ongoing friction — China "serious concern" over new US trade restrictions (07-31), China countermeasures after US sanctions (08-05), China weighing response to possible new US tariff round (08-27), US accuses Chinese exporters of transshipment scheme (08-15) (all reported, GDELT).
# Event
Will the US and China reach a publicly announced, mutual tariff agreement between market creation and Dec 31, 2026?
# Outcomes to forecast
- Yes
- No
# Kalshi market anchor
No Kalshi-direct price was returned for this specific ticker in the raw research (tool output absent). The primary anchor available is Polymarket-direct: **84.75% YES**, down from a 90-day high of 92.2% (7-day and 30-day trend both -5.1%), on $236,607 total volume over 90 days. Trend suggests softening confidence, consistent with the ambiguous May 2026 summit outcome and Bessent's "not in a rush" comments.
# Sub-question answers
1. **Current Polymarket YES price/trajectory** — 84.75%, down 5.1% over both 7d and 30d windows; range 69.5%-92.2% over 90 days [polymarket_direct].
2. **Market creation vs. Busan truce timing** — Busan truce (Oct 30, 2025) predates the visible 90-day Polymarket price window; the current elevated price (~85-92%) implies the market treats Busan/Nov 2025 fact sheet as strong (if not conclusive) evidence toward YES, though resolution ambiguity remains over whether it counts as a "finalized" agreement [polymarket_direct, code_execution inference].
3. **Current truce status/expiry** — Fentanyl tariff cut 20%→10%, 100% threatened hike suspended, 24% reciprocal tariff cut extended through Nov 10, 2026; China's tariff-exclusion process for US imports extended through Dec 31, 2026; soybean purchases and chip-probe terminations included [wiley.law, whitehouse.gov].
4. **Scheduled 2026 summits** — Trump already made a Beijing state visit May 13-15, 2026 (yielded vague "deals," disputed by Beijing) [Wikipedia, CNN]; further Trump-Xi meetings possible at Nov 2026 APEC (China) and Dec 2026 G20 (Florida) [Al Arabiya].
5. **Historical base rate** — 5 qualifying US-China tariff agreements/truces 2018-2025; long-run rate ~0.625/yr (Poisson P≈46.5%), but 2025-only rate ~3/yr (Poisson P≈95%), reflecting a currently active negotiation regime [code_execution].
6. **Cross-market pricing differences** — Related Kalshi markets price adjacent outcomes much lower: "Free trade agreement with China before 2029" at 15% (down 14pp/30d), reflecting a much higher bar (comprehensive FTA) than this market's "any mutual tariff agreement" [kalshi_related].
# Key facts (high-confidence, factual)
1. [wiley.law] Busan truce (Oct 30, 2025): one-year deal, fentanyl tariff 20%→10%, 24% reciprocal tariff cut extended to Nov 10, 2026.
2. [whitehouse.gov] Formal fact sheet (Nov 2025): China tariff-exclusion process extended to Dec 31, 2026; soybean and chip-probe commitments.
3. [Wikipedia] Trump made a state visit to Beijing May 13-15, 2026.
4. [CNN] May 2026 summit outcomes described as vague/disputed, not a clean comprehensive deal.
5. [Al Arabiya] As of May 20, 2026, Bessent said US not rushing to extend/renew truce before Nov 10, 2026 expiry.
6. [GDELT] Trade tensions persist into Jul-Aug 2026 (sanctions, countermeasures, transshipment accusations).
# Cross-market signals
- Kalshi related: "Free trade agreement with China before 2029" at 15% (much stricter bar); "China obtains EUV machine" 11%; not directly comparable but shows market skepticism toward deep/structural deals.
- Polymarket (this market): 84.75%, declining trend.
- No sportsbook data applicable.
# Analyst opinions and speculation
- Analysts characterize Busan as a "tactical truce," not a structural resolution; core disputes (Taiwan, tech/semiconductors, TikTok) unresolved [claude_news synthesis].
- Bessent suggests China may accept restored Section 301 tariffs if not raised further, adding legal complexity [Al Arabiya].
- Possible Nov 2026 APEC/Dec 2026 G20 meetings seen as venues for renewal, but no confirmed commitment.
# Directional lean per outcome
- **Yes**: Existing Busan framework + Nov 2025 fact sheet arguably already constitutes a "mutual agreement" under the loose resolution language (mutual tariff reductions, publicly announced); high-frequency 2025 precedent (3 deals/truces in one year); scheduled Nov/Dec 2026 summits offer renewal opportunities; Polymarket pricing 85%.
- **No**: May 2026 summit produced only vague, disputed outcomes, not a clean new formal agreement; Bessent explicitly said no rush to formalize; ongoing tension escalations (sanctions, tariff threats) through mid-2026; strict reading of "finalized agreement" (vs. informal truce) could fail resolution; declining price trend (-5% over 30d) signals growing doubt.
# Gaps / unknowns
- No direct Kalshi price for this specific ticker was returned — anchor relies on Polymarket.
- Unclear whether resolution committee will count Busan/Nov 2025 fact sheet (pre-dating close year) as satisfying "agreement" for the Dec 31, 2026 window, or require a fresh 2026 event.
- No confirmed outcome from Nov 2026 APEC or Dec 2026 G20 in available data (news cutoff ~Aug 2026).
- Ambiguity in "informal vs. finalized agreement" definition remains unresolved by reporting to date.
# Calibration anchors
- Polymarket current YES price: 84.75% (anchor), down from 92.2% high.
- Base rate: long-run Poisson ~46.5%; recent (2025) rate-implied ~95%; blended analyst estimate ~85-96%, point ~91%.
- Precedent: US-China reached some form of tariff-related agreement/truce in 2018, 2020, and three times in 2025 — high frequency in active-negotiation years.